Truvestments Capital »

Lyell Immunopharma shares owned by Truvestments Capital

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Truvestments Capital from 13F filings

Historical chart of Truvestments Capital investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Truvestments Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Truvestments Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.2k 300 14.05

More positions owned by Truvestments Capital

NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Corning Incorporated (GLW)
Broadcom (AVGO)
Apple (AAPL)
Caterpillar (CAT)
Applied Materials (AMAT)
Celestica (CLS)
Dell Technologies CL C (DELL)
Qualcomm (QCOM)
Marvell Technology (MRVL)
Ryder System (R)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Johnson & Johnson (JNJ)

View all positions for Truvestments Capital

Top funds holding Lyell Immunopharma

Arch Venture Corp
GSK
Vanguard Capital Management
Orland Properties
BlackRock
Almitas Capital
Foresite Capital Management V
Millennium Management
Opaleye Management
venBio Partners
Geode Capital Management
Alphabet
Sc China Holding
Renaissance Technologies
Northern Trust

View all funds holding Lyell Immunopharma